LETROZOLE COMPARED WITH CLOMPIHENE CITRATE FOR POLYCYSTIC OVARIAN SYNDROME : A SYSTEMATIC REVIEW
نویسندگان
چکیده
According to the Consensus on Management of PCOS, polycystic ovary syndrome, is an endocrine condition that produces oligo-anovulation, clinical and biochemical symptoms hyperandrogenism, distinctive ovarian morphological characteristics ultrasonographic examination. PCOS also associated with a higher risk endometrial cancer. Both hyperandrogenism anovulation are difficult conditions manage. women often have GnRH pulsatility, which in turn causes increased pituitary LH secretion elevated LH/FSH ratio. Granulosa cells responsible for conversion androgens estrogen maturation follicles, while promoting androgen synthesis theca cells. Intraovarian produce atresia later antral stages, although they do boost initial follicle recruitment by increasing preantral early growth. In contrast CC its own, letrozole was shown increase number live births, overall level evidence moderate. There insufficient there difference rate births between plus metformin alone, certainty poor due bias imprecision. When contrasted use itself, potential benefit combination more apparent whose baseline blood insulin or HOMA-IR values were than average. comparison clomiphene citrate, related rates ovulation, pregnancy, successful delivery baby. Despite fact quality data inconsistent, one study recommends over citrate as ovulation induction medicine who infertility PCOS.
منابع مشابه
P-199: Comparison of Clomiphene Citrate and Letrozole Effect on Folliculogenesis in Polycystic Ovarian Syndrome Patients
Background: Polycystic ovarian syndrome (PCOS) which is the most common form of anovulatory infertility affects 5-10% women of reproductive age. Clomiphene Citrate (C.C) is the first line treatment in infertile women entering intrauterine insemination (IUI) cycle. For C.C resistant patients the second approach is aromatase inhibitors such as Letrozole. The aim of this study is to compare the ef...
متن کاملComparison of Letrozole Versus Tamoxifen Effects in Clomiphen Citrate Resistant Women with Polycystic Ovarian Syndrome
BACKGROUND The objective of this prospective randomized study was to make a comparison between the effects of letrozole and tamoxifen (TMX) in ovulation induction in clomiphene (CC)-resistant women with polycystic ovarian syndrome (PCOS). METHODS The study comprised a total of 60 infertile women (180 cycles) with CCresistant PCOS selected from the clinics affiliated to the Department of Obste...
متن کاملcomparison of letrozole versus tamoxifen effects in clomiphen citrate resistant women with polycystic ovarian syndrome
background: the objective of this prospective randomized study was to make a comparison between the effects of letrozole and tamoxifen (tmx) in ovulation induction in clomiphene (cc)-resistant women with polycystic ovarian syndrome (pcos). methods: the study comprised a total of 60 infertile women (180 cycles) with cc-resistant pcos selected from the clinics affiliated to the department of obst...
متن کاملLetrozole versus Clomiphene Citrate for Induction of Ovulation in Patients with Polycystic Ovarian Syndrome Undergoing Intrauterine Insemination
BACKGROUND Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies affecting women in the reproductive age group, and is one of the most common causes of hyperandrogenic anovulatory infertility. The aromatase inhibitor, letrozole, has been used for induction of ovulation. The purpose of this study was to compare the effects of letrozole and clomiphene citrate in induction of...
متن کاملRandomized controlled trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate-resistant polycystic ovary syndrome
The aim of the present study was to compare the reproductive outcomes of letrozole and laparoscopic ovarian drilling (LOD) in women with clomiphene citrate (CC)-resistant polycystic ovary syndrome (PCOS). A total of 141 women with CC-resistant PCOS were enrolled and randomly allocated into groups A and B. Group A (n=71) received 2.5 mg letrozole from days 5 to 10 of menses for up to six cycles,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of advanced research in Medical and Health science
سال: 2023
ISSN: ['2208-2425']
DOI: https://doi.org/10.53555/nnmhs.v9i5.1701